Review – Treatment of Helicobacter pylori infection 2020

A O'Connor, T Furuta, JP Gisbert, C O'Morain - Helicobacter, 2020‏ - Wiley Online Library
This review summarizes important studies regarding Helicobacter pylori therapy published
from April 2019 to April 2020. The main themes that emerge involve studies assessing …

Advances and challenges in cancer immunoprevention and immune interception

SE Stanton, PE Castle, OJ Finn, S Sei… - … for immunotherapy of …, 2024‏ - pmc.ncbi.nlm.nih.gov
Invasive cancers typically evade immune surveillance through profound local and systemic
immunosuppression, preventing their elimination or control. Targeting immune interventions …

The prevalence of clarithromycin-resistant Helicobacter pylori isolates: a systematic review and meta-analysis

M Sholeh, S Khoshnood, T Azimi, J Mohamadi… - PeerJ, 2023‏ - peerj.com
Background Knowledge of global clarithromycin (CLA)-resistant rates of Helicobacter pylori
(H. pylori) is crucial for decision of the most appropriate eradication therapies with good …

[HTML][HTML] Detection of clarithromycin resistance and 23SrRNA point mutations in clinical isolates of Helicobacter pylori isolates: Phenotypic and molecular methods

RA Hussein, MTS Al-Ouqaili, YH Majeed - Saudi journal of biological …, 2022‏ - Elsevier
Background and objectives Peptic ulcer disease, chronic gastritis, and stomach cancer are
all caused by H. pylori. The most notable drug for the treatment is the antibiotic …

Evidence of Helicobacter pylori heterogeneity in human stomachs by susceptibility testing and characterization of mutations in drug-resistant isolates

JM Islam, Y Yano, A Okamoto, R Matsuda… - Scientific Reports, 2024‏ - nature.com
Heterogeneity of Helicobacter pylori communities contributes to its pathogenicity and
diverse clinical outcomes. We conducted drug-susceptibility tests using four antibiotics …

Clinical evaluation of a real-time PCR assay for simultaneous detection of Helicobacter pylori and genotypic markers of clarithromycin resistance directly from stool

R Marrero Rolon, SA Cunningham… - Journal of clinical …, 2021‏ - journals.asm.org
Helicobacter pylori infection is mainly diagnosed noninvasively, with susceptibility testing
traditionally requiring endoscopy. Treatment is empirical, with clarithromycin-based triple …

Effects of CYP2C19 genetic polymorphisms on the cure rates of H. pylori in patients treated with the proton pump inhibitors: An updated meta-analysis

X Zhao, Z Zhang, F Lu, M **
J Yao, Z Zhang, X Huang, Y Guo - Biosensors and Bioelectronics, 2022‏ - Elsevier
Single nucleotide variants in CYP2C19* 2 are associated with clopidogrel resistance in
coronary heart disease. In order the guidance the dosage of drug and personalized …